NDC 16110-833 – Tazorac

Tazarotene .5 mg/g · Gel · Cutaneous

Human Prescription Drug

Product NDC16110-833

Product details

Brand name
Tazorac
Generic name
Tazarotene
Labeler
Almirall, LLC
Dosage form
Gel
Route
Cutaneous
Marketing category
NDA · NDA020600
Marketed since
February 21, 2020
Listing expires
December 31, 2026
Pharmacologic class
Retinoid

Active ingredients

Uses, dosage, side effects and warnings for Tazorac →

Package NDC codes (2)

Package NDCDescriptionSince
16110-833-101 TUBE in 1 CARTON (16110-833-10) / 100 g in 1 TUBEFeb 21, 2020
16110-833-301 TUBE in 1 CARTON (16110-833-30) / 30 g in 1 TUBEFeb 21, 2020

Other Tazorac products